VBIO
Valion Bio, Inc. Common Stock
Nasdaq · usd
Valion Bio, Inc. Common Stock (VBIO) trades at $0.8400 (-10.60%) as of 4:12:26 PM EDT on Oct 26, 2026, -72.94% over the past month. Market cap is $834.33K, with 1.0 days to cover in short interest.
Stock performance
How Valion Bio, Inc. Common Stock (VBIO) stock has performed from one day to one year, with its 52-week range.
- 1D
- -12.78%
- 1W
- -29.32%
- 1M
- -72.94%
- YTD
- -96.75%
- 1Y
- -96.75%
- 52-wk range
- $0.68 – $32.50
Key statistics
Today's trading snapshot for VBIO: day range, open, previous close, volume and market cap.
- Day range
- $0.68 – $0.90
- Open
- $0.90
- Prev close
- $0.94
- Volume
- 17.35M
- Market cap
- $834.33K
- Shares out
- 2.16M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Valion Bio, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 5.71
- P/B
- 0.20
- P/FCF
- —
- ROE
- -385.8%
- ROA
- -50.4%
- Debt/Equity
- 1.74
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Valion Bio, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Private placementOct 8, 2026
On October 7, 2026, the Company and 3i entered into a letter agreement ... pursuant to which 3i agreed to purchase, and the Company agreed to issue to 3i, (a) 50 Series B Preferred Shares and (b) Series B Warrants to purchase 1,539 shares of Common Stock ... for an aggregate purchase price of $50,000 ... Such securities were issued under an exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) promulgated thereunder.
- Product or service launchOct 1, 2026
On September 30, 2026, Valion Bio, Inc. (the "Company") issued a press release announcing the completion of formulation work to develop a novel oral mucosal formulation of Entolimod using Shear Kershman Laboratories' proprietary BioViscid™ drug-delivery platform.
- Ceo appointmentSep 23, 2026
On September 22, 2026, Valion Bio, Inc. (the "Company") appointed Dean Zikria as Interim Chief Executive Officer of the Company, effective immediately. Mr. Zikria remains a member of the Company's Board of Directors.
- Stock splitSep 1, 2026
The number of shares of Common Stock underlying the Closing Warrants and the exercise price thereof give effect to the Company’s 1-for-25 reverse stock split effective at 12:01 a.m. Eastern Time on August 31, 2026.
- Charter amendmentAug 27, 2026
On August 26, 2026, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the "Charter Amendment"), with the Secretary of State of the State of Delaware, pursuant to which, effective August 31, 2026, the Reverse Split will be effected.
Dividend history and stock splits
Valion Bio, Inc. Common Stock's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-25Aug 31, 2026
VBIO short interest
How heavily VBIO is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 87.97K
- Avg volume
- 5.96M
As of · reported to FINRA twice monthly.
Frequently asked questions
What is the Valion Bio, Inc. Common Stock (VBIO) stock price today?
Valion Bio, Inc. Common Stock (VBIO) is trading at $0.8400 (-10.60% on the day) as of 4:12:26 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Valion Bio, Inc. Common Stock?
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets…
What is the short interest in VBIO?
As of Sep 30, 2026, VBIO has 87.97K shares short and 1.0 days to cover.
What exchange is VBIO listed on?
Valion Bio, Inc. Common Stock (VBIO) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of VBIO with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a VBIO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.